Literature DB >> 22290147

Characterization of a novel inactivated Salmonella enterica serovar Enteritidis vaccine candidate generated using a modified cI857/λ PR/gene E expression system.

Chetan V Jawale1, Atul A Chaudhari, Byung Woo Jeon, Rahul M Nandre, John Hwa Lee.   

Abstract

A new strategy to develop an effective vaccine is essential to control food-borne Salmonella enterica serovar Enteritidis infections. Bacterial ghosts (BGs), which are nonliving, Gram-negative bacterial cell envelopes, are generated by expulsion of the cytoplasmic contents from bacterial cells through controlled expression using the modified cI857/λ P(R)/gene E expression system. In the present study, the pJHL99 lysis plasmid carrying the mutated lambda pR37-cI857 repressor and PhiX174 lysis gene E was constructed and transformed in S. Enteritidis to produce a BG. Temperature induction of the lysis gene cassette at 42°C revealed quantitative killing of S. Enteritidis. The S. Enteritidis ghost was characterized using scanning and transmission electron microscopy to visualize the transmembrane tunnel structure and loss of cytoplasmic materials, respectively. The efficacy of the BG as a vaccine candidate was evaluated in a chicken model using 60 10-day-old chickens, which were divided into four groups (n = 15), A, B, C, and D. Group A was designated as the nonimmunized control group, whereas the birds in groups B, C, and D were immunized via the intramuscular, subcutaneous, and oral routes, respectively. The chickens from all immunized groups showed significant increases in plasma IgG and intestinal secretory IgA levels. The lymphocyte proliferation response and CD3(+) CD4(+) and CD3(+) CD8(+) T cell subpopulations were also significantly increased in all immunized groups. The data indicate that both humoral and cell-mediated immune responses are robustly stimulated. Based on an examination of the protection efficacy measured by observations of gross lesions in the organs and bacterial recovery, the candidate vaccine can provide efficient protection against virulent challenge.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290147      PMCID: PMC3318409          DOI: 10.1128/IAI.06264-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis.

Authors:  T G Bernhardt; W D Roof; R Young
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 2.  Bacterial ghosts as vaccine candidates for veterinary applications.

Authors:  Katri Jalava; Andreas Hensel; Michael Szostak; Stephanie Resch; Werner Lubitz
Journal:  J Control Release       Date:  2002-12-13       Impact factor: 9.776

3.  Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.

Authors:  A Hensel; V Huter; A Katinger; P Raza; C Strnistschie; U Roesler; E Brand; W Lubitz
Journal:  Vaccine       Date:  2000-07-01       Impact factor: 3.641

4.  Immunogenicity of a Salmonella Enteritidis mutant as vaccine candidate and its protective efficacy against salmonellosis in chickens.

Authors:  Rahul M Nandre; Atul A Chaudhari; Kiku Matsuda; John Hwa Lee
Journal:  Vet Immunol Immunopathol       Date:  2011-08-26       Impact factor: 2.046

5.  Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium.

Authors:  S J McSorley; B T Cookson; M K Jenkins
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

6.  Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine.

Authors:  Ho Young Kang; Jay Srinivasan; Roy Curtiss
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.

Authors:  Klaus Panthel; Wolfgang Jechlinger; Alexander Matis; Manfred Rohde; Michael Szostak; Werner Lubitz; Rainer Haas
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates.

Authors:  J Marchart; G Dropmann; S Lechleitner; T Schlapp; G Wanner; M P Szostak; W Lubitz
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

9.  Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.

Authors:  Francis O Eko; Tatiana Schukovskaya; E Y Lotzmanova; V V Firstova; N V Emalyanova; S N Klueva; A L Kravtzov; L F Livanova; Vladimir V Kutyrev; Joseph U Igietseme; Werner Lubitz
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

10.  Antibody responses in the serum and gut of chicken lines differing in cecal carriage of Salmonella enteritidis.

Authors:  Florence Berthelot-Hérault; Florence Mompart; Michel S Zygmunt; Gérard Dubray; Marion Duchet-Suchaux
Journal:  Vet Immunol Immunopathol       Date:  2003-11-15       Impact factor: 2.046

View more
  13 in total

1.  Generation of a Novel Staphylococcus aureus Ghost Vaccine and Examination of Its Immunogenicity against Virulent Challenge in Rats.

Authors:  Nagarajan Vinod; Sung Oh; Hyun Jung Park; Jung Mo Koo; Chang Won Choi; Sei Chang Kim
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

2.  Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine model.

Authors:  Chan Song Kim; Jin Hur; Seong Kug Eo; Sang-Youel Park; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

3.  Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.

Authors:  Chetan V Jawale; John Hwa Lee
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

4.  Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection.

Authors:  Vijayakumar Jawalagatti; Perumalraja Kirthika; Ji-Young Park; Chamith Hewawaduge; John Hwa Lee
Journal:  J Adv Res       Date:  2021-07-22       Impact factor: 10.479

5.  Development of a biosafety enhanced and immunogenic Salmonella enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system.

Authors:  Chetan V Jawale; John Hwa Lee
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

6.  Characterization of Chemically-Induced Bacterial Ghosts (BGs) Using Sodium Hydroxide-Induced Vibrio parahaemolyticus Ghosts (VPGs).

Authors:  Hyun Jung Park; Sung Oh; Nagarajan Vinod; Seongmi Ji; Han Byul Noh; Jung Mo Koo; Su Hyeong Lee; Sei Chang Kim; Ki-Sung Lee; Chang Won Choi
Journal:  Int J Mol Sci       Date:  2016-11-15       Impact factor: 5.923

7.  Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry.

Authors:  Sankar Renu; Ashley D Markazi; Santosh Dhakal; Yashavanth S Lakshmanappa; Suren R Gourapura; Revathi Shanmugasundaram; Sujata Senapati; Balaji Narasimhan; Ramesh K Selvaraj; Gourapura J Renukaradhya
Journal:  Int J Nanomedicine       Date:  2018-11-30

8.  A Novel and Efficient High-Yield Method for Preparing Bacterial Ghosts.

Authors:  Yi Ma; Liu Cui; Meng Wang; Qiuli Sun; Kaisheng Liu; Jufang Wang
Journal:  Toxins (Basel)       Date:  2021-06-13       Impact factor: 4.546

9.  Immunological changes at point-of-lay increase susceptibility to Salmonella enterica Serovar enteritidis infection in vaccinated chickens.

Authors:  Claire E Johnston; Catherine Hartley; Anne-Marie Salisbury; Paul Wigley
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

10.  A Salmonella typhimurium ghost vaccine induces cytokine expression in vitro and immune responses in vivo and protects rats against homologous and heterologous challenges.

Authors:  Nagarajan Vinod; Han Byul Noh; Sung Oh; Seongmi Ji; Hyun Jung Park; Ki-Sung Lee; Sei Chang Kim; Han-Oh Park; Joo-Sung Yang; Chang Won Choi
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.